1O Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC

• DOI: 10.1016/j.annonc.2021.10.017
• Publication Date: 2021-12-10T14:08:22Z
• Authors: M.G. Kris; J.M. Grindheim; J.E. Chaft; J.M. Lee; B.E. Johnson; V.W. Rusch; P.A. Bunn; H. Pass; E. Schum; J. Carlisle; M. Weyant; A. Nicholas; A. Johnson; D. Shames; I.I. Wistuba; D.P. Carbone; K. Schulze; D.J. Kwiatkowski
• Keywords: Atezolizumab; Neoadjuvant Therapy